News
ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
ServiceNow Inc. (NYSE: NOW) is down 11% at the end of the week, in which the company delivered its fourth-quarter earnings report. The headline numbers were fine, and revenue of $2.96 billion
Microsoft and Meta's AI Investment Plans Are Full Steam Ahead
Giants in the tech industry are reporting earnings for the first time in 2025 to much anticipation. Investors have been eager to hear how hyperscalers will respond to DeepSeek, which shook
Beyond Self-Driving Cars: Factory Automation Takes Center Stage
While the image of self-driving cars effortlessly navigating city streets dominates headlines, a quieter yet equally transformative revolution is underway within the confines of factories and
MarketBeat Week in Review – 01/27 - 01/31
Stocks closed the week slightly higher after Monday’s sell-off prompted by concerns over China’s DeepSeekopen-source API. In fact, the tech-heavy NASDAQ index was on pace to be the best-performing
Trump 2.0: This Sector May See A Big Performance Boost
Now that Donald Trump is starting his second term as President, reviewing sector performance during his first term is an interesting exercise. Some of the results may come as a surprise
Apple Stock: AI Features Drive 3.7% Surge, Record Valuation
Apple's stock demonstrated remarkable strength with a 3.7% increase in early US trading, pushing the tech giant's market capitalization to an impressive $3.57 trillion. This surge was primarily
Nebius Group: Market Overreaction or Real AI Disruption?
Shares of Nebius Group (NASDAQ: NBIS) took a nosedive on Monday, plummeting nearly 40% following the release of DeepSeek’s latest AI model. The shockwave of this announcement caused fear-driven
The Best Way to Invest in Gold Is...
Gold prices repeatedly reached new highs in 2024 and are again nearing record levels. Multiple factors, including rising geopolitical tensions and the consequent demand for safe-haven assets
Why Nike Stock Could Be 2025’s Top Comeback Play
Nike Inc (NYSE: NKE) shares have been continuing to consolidate after a painful three-year downtrend that finally looks to be running out of steam. 2021's all-time high seems a long way away
Uber Stock Gaining Speed: Analysts See 30% Upside
Uber Technologies Inc. (NYSE: UBER) shares have demonstrated solid resilience in recent weeks as they continue gaining momentum after a choppy 2024. While the stock is still some way off last
AbbVie Investors Trigger Trend-Following Signal: Time to Load Up
AbbVie (NYSE: ABBV) is a high-quality, dividend-growing pharmaceutical company with a robust outlook for growth: now is a good time to load up on shares. Fears of Humira’s patent cliff are
Whirlpool: Buy This High-Yielding Value Before It Spins Higher
Whirlpool’s (NYSE: WHR) FQ4 2024 results and guidance for 2025 were lackluster, but they did not provide any real reason for the stock price to sell off the way it did. Tepid relative to
3 Turnaround Stocks in the Early Innings With More Upside to Come
“Turnaround” is a magic word for investors looking to get into a stock at cheap valuations. It’s a key justification for entering stocks that have been left for dead. It's also a term that gets
Commvault Systems: Share Price Primed to Vault Higher in 2025
Commvault Systems (NASDAQ: CVLT) share price trended higher in 2023 and 2024, gaining more than 150% at the movement's peak, and can continue to trend higher in 2025 and beyond. The reason is
3 Unsung Beneficiaries of the Stargate Project
Two massive developments have come out in recent weeks surrounding the AI investment landscape. The first came on Jan. 21, with the announcement of The Stargate Project. It looks to invest $500
3 Chemical Stocks Defying Tariff Worries With Growth Potential
The market has been worried about the potential implications of President Trump's new tariffs on some of the United States’ biggest trading partners. The latest announcements were made for
Starbucks’ CEO-Led Turnaround Gains Traction: New Highs Likely
Starbucks' (NASDAQ: SBUX) outlook is improving, with Brian Niccol at the helm, and new all-time highs will likely be achieved by the end of this year. Now, more than a full quarter into the
Microsoft Stock: AI Investments Surge Despite Growth Concerns
Microsoft's stock performance in 2024 has demonstrated remarkable resilience, achieving approximately 20% growth despite recent fluctuations. While the stock currently trades around 411 euros
ServiceNow Stock: Mixed Q4 Results Trigger 9% Drop
ServiceNow delivered a strong fourth-quarter performance in 2024, yet its shares tumbled 9% in after-hours trading despite beating Wall Street expectations. The Santa Clara-based software company
How Growth Investors Find High-Growth Stocks and Maximize Returns
Saying that growth investing is all about short-term profits is a misnomer. Just ask anyone who has spent the last 20 years invested in Apple Inc. (NASDAQ: AAPL) or Amazon Inc. (NASDAQ: AMZN) if
Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
Meta Platforms' (NASDAQ: META) uptrend will continue because the business is evolving into an enduring, blue-chip consumer technology leader akin to Apple (NASDAQ: AAPL). Among the highlights
NVIDIA's Slide Continues: Can Retail Investors Stop the Fall?
NVIDIA Corp. (NASDAQ: NVDA) stock returned to its lows of the week on January 30. Down more than 16% for the week, the question on many investors' minds is what will it take to stop the slide?
Microsoft Stock Breaks Trend, But It Doesn’t Matter—Here’s Why
Microsoft's (NASDAQ: MSFT) stock price plunged more than 6% following its FQ2 earnings report and broke the uptrend, but it doesn’t matter. The results were strong, and the long-term opportunity
How Value Investors Find Undervalued Stocks and Build Wealth
You can't mention value investing without mentioning legendary value investor Warren Buffett. Buffett. You may have heard one of his most famous quotes: "Price is what you pay. Value is what you
Is Tonix Pharmaceuticals the Next Biotech Breakout?
Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for


